Abstract:Necroptosis is a form of programmed cell death executed by receptor-interacting serine/threonine protein kinase 1 (RIPK1), RIPK3, and mixed lineage kinase domain-like (MLKL). Platelets are circulating cells that play central roles in haemostasis and pathological thrombosis. In this study we demonstrate seminal contribution of MLKL in transformation of agonist-stimulated platelets to active haemostatic units progressing eventually to necrotic death on a temporal scale, thus attributing a yet unrecognized fundamental role to MLKL in platelet biology. Physiological agonists like thrombin instigated phosphorylation and subsequent oligomerization of MLKL in platelets in a RIPK3-independent but phosphoinositide 3-kinase (PI3K)/AKT-dependent manner. Inhibition of MLKL significantly curbed agonist-induced haemostatic responses in platelets that included platelet aggregation, integrin activation, granule secretion, procoagulant surface generation, rise in intracellular calcium, shedding of extracellular vesicles, platelet-leukocyte interactions and thrombus formation under arterial shear. MLKL inhibition, too, prompted impairment in mitochondrial oxidative phosphorylation and aerobic glycolysis in stimulated platelets, accompanied with disruption in mitochondrial transmembrane potential, augmented proton leak and drop in both mitochondrial calcium as well as ROS. These findings underscore the key role of MLKL in sustaining OXPHOS and aerobic glycolysis that underlie energy-intensive platelet activation responses. Prolonged exposure to thrombin provoked oligomerization and translocation of MLKL to plasma membranes forming focal clusters that led to progressive membrane permeabilization and decline in platelet viability, which was prevented by inhibitors of PI3K/MLKL. In summary, MLKL plays vital role in transitioning of stimulated platelets from relatively quiescent cells to functionally/metabolically active prothrombotic units and their ensuing progression to necroptotic death.

The Many Faces of MLKL, the Executor of Necroptosis

The MLKL Channel in Necroptosis is an Octamer Formed by Tetramers in a Dyadic Process.

The molecular mechanisms of MLKL-dependent and MLKL-independent necrosis

Necrosome core machinery: MLKL

Uncovering human mixed lineage kinase domain-like activation in necroptosis

Death at a funeral: Activation of the dead enzyme, MLKL, to kill cells by necroptosis

Surviving death: emerging concepts of RIPK3 and MLKL ubiquitination in the regulation of necroptosis

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Biological events and molecular signaling following MLKL activation during necroptosis

Oligomerization-driven MLKL ubiquitylation antagonizes necroptosis

MLKL in cancer: more than a necroptosis regulator

MLKL post-translational modifications: road signs to infection, inflammation and unknown destinations

MLKL forms disulfide bond-dependent amyloid-like polymers to induce necroptosis

Molecular Insights into the Mechanism of Necroptosis: The Necrosome as a Potential Therapeutic Target

The brace helices of MLKL mediate interdomain communication and oligomerisation to regulate cell death by necroptosis

Necroptosis executioner MLKL plays pivotal roles in agonist-induced platelet prothrombotic responses and lytic cell death in a temporal order

Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis

Direct Activation of Human MLKL by a Select Repertoire of Inositol Phosphate Metabolites

Acylation of MLKL Impacts Its Function in Necroptosis

Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization

Necroptosis: Mechanisms and Relevance to Disease.